|
|
|
Volumn 26, Issue 4, 2007, Pages 394-397
|
|
Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III-IVa nasopharyngeal carcinoma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
ADJUVANT CHEMOTHERAPY;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
LYMPH NODE METASTASIS;
MALE;
MEGAVOLTAGE RADIOTHERAPY;
MIDDLE AGED;
MUCOSA INFLAMMATION;
MULTIMODALITY CANCER THERAPY;
NASOPHARYNX TUMOR;
PATHOLOGY;
RADIATION DOSE FRACTIONATION;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
DISEASE-FREE SURVIVAL;
DOSE FRACTIONATION;
FEMALE;
FLUOROURACIL;
HUMANS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
MUCOSITIS;
NASOPHARYNGEAL NEOPLASMS;
NEOPLASM STAGING;
RADIOTHERAPY, HIGH-ENERGY;
REMISSION INDUCTION;
SURVIVAL RATE;
|
|
EID: 70350438193
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
